← Back to Search

Diagnostic Device

Fundus camera image for Diabetic Retinopathy

N/A
Waitlist Available
Research Sponsored by Digital Diagnostics, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up ~1-month after day 1
Awards & highlights
No Placebo-Only Group

Summary

A multi-center study to evaluate the performance of an automated device for the detection of diabetic retinopathy with the use of an additional fundus camera with IDx-DR.

Eligible Conditions
  • Diabetic Retinopathy

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~~1-month after day 1
This trial's timeline: 3 weeks for screening, Varies for treatment, and ~1-month after day 1 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Sensitivity and Specificity Corrected for Enrichment
Secondary study objectives
Observed Sensitivity and Specificity, Level II
Other study objectives
Precision substudy

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Fundus camera imageExperimental Treatment1 Intervention
Subjects imaged with a fundus camera

Find a Location

Who is running the clinical trial?

FortreaUNKNOWN
17 Previous Clinical Trials
4,640 Total Patients Enrolled
Digital Diagnostics, Inc.Lead Sponsor
4 Previous Clinical Trials
2,593 Total Patients Enrolled
4 Trials studying Diabetic Retinopathy
2,593 Patients Enrolled for Diabetic Retinopathy
Laboratory Corporation of AmericaIndustry Sponsor
31 Previous Clinical Trials
18,077 Total Patients Enrolled
~235 spots leftby Nov 2025